New Jersey
Rare disease specialist Insmed continues rapid growth in NJ
Insmed is a biopharmaceutical company that develops and commercializes drugs for serious and rare diseases – advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving the most pressing patient needs. Its most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the U.S., Europe and Japan to treat a chronic, debilitating lung disease.
The Bridgewater-based business is poised for even more in New Jersey.
In addition to its Somerset County headquarters, Insmed also has offices and research locations around the world – including a separate R&D facility Bridgewater. NJBIZ recently toured that facility to learn more.
The company is led by Will Lewis, who joined Insmed in 2012 after a stint in investment banking. Under his watch, the company has grown from a 30-person biotech company to a more than 1,200-person emerging global biopharmaceutical company with a nearly $13 billion market cap.
In October, Insmed earned the highest ranking in Science’s 2024 Top Employers Survey.
“It is a tremendous honor to have been named the No. 1 employer in Science’s annual survey for the fourth consecutive year,” said Lewis in an Oct. 24 statement. “This past year has been transformational for our company, as we’ve demonstrated the strength of our commercial and pipeline programs, continued to fuel the innovation engine behind our early-stage research, and enhanced our culture while growing to more than 1,200 employees around the world. Looking to the future, I am filled with pride and excitement as I think about the talent, dedication, and potential of our team as we strive to make a real difference in the lives of patients with serious diseases.”
“The culture we’ve built at Insmed is unlike any other I’ve experienced, and I am proud to see it continue to grow and strengthen as we expand our global team,” said Nicole Schaeffer, chief people strategy officer, Insmed. “Thank you to our colleagues around the world who show up every day with a desire to help patients, enrich our communities, and support one another. It is because of you that we have once again been recognized by Science as the top employer in the biopharma industry.”
In February, at BioNJ’s 31st Annual Dinner Meeting & Innovation Celebration, Lewis received the Dr. Sol J. Barer Award for Vision, Innovation, and Leadership.
“Often described as one of the humblest people in the industry, it is with immense pleasure that I present this year’s award to a truly fine human being – an individual who epitomizes vision, innovation, and leadership through tireless advocacy for patients, the health care system, and New Jersey’s life sciences ecosystem,” said Barer, former chair and CEO at Celegene Corp. and chair of the board at Teva Pharmaceutical Industries, as he presented his namesake award.
“It struck me as I was walking up here that prior recipients and, indeed, going all the way back to when you began – have literally altered the lives or saved the lives of thousands, if not, millions of patients,” said Lewis. “That’s quite a remarkable achievement. It’s a daunting thing to receive this award – and I think I could spend the rest of my career trying to earn its worth, so thank you.
The greatest companies are forged during the most difficult times.
– Will Lewis, Insmed CEO
“For those of you in the room who are trying to build companies, I have been coming to this event for a long time,” said Lewis. “I was previously at a different company that struggled for many years – failing to go public three times before it eventually found success. I joined Insmed 11 years ago when it had a zero-enterprise value. Wall Street said we were worth nothing. Maybe this sounds familiar to some of you who are currently trying to build companies and run them during the worst market correction in several decades. My message to you is this – hold fast, your time will come. You can do this.”
Lewis noted that BioNJ and the attendees in the room were there to help entrepreneurs build companies.
“The greatest companies are forged during the most difficult times. And that means there are a lot of great companies being made right now – yours among them,” Lewis explained.
Preserving company culture
NJBIZ recently caught up with the Insmed CEO to discuss the latest happenings and milestones at the company, what’s on the horizon and more.
The conversation opened with Lewis lauding the efforts and passion of his team. He detailed how important culture and collaboration are at Insmed, which was on full display during the NJBIZ visit to the R&D facility.
“Honestly, it’s the thing that I’m the most proud of at the company,” he said, recounting a recent town hall. “We’ve gone from 30 people when I joined to 1,200 – and we’ll go to 1,700 at the end of next year. Actually, the biggest question that people have is – how do we preserve our culture? Because as we’ve gone through that journey, we’ve sort of maintained this commitment – everybody in this industry says they’re about the patient. But it takes about five minutes when you walk into any company to know – is that authentic? Is the screen that shows the CNBC channel bigger than the one that talks about what the medicine might do? You get the signals rather quickly.
“We want people to bring their authentic selves to work – feel like they are in a place where they can do their best work,” he continued. “And we always say to folks – the mantra that should be in your head is: How can I help? And if we can get that, then you really don’t have to manage anybody.”
Lewis spoke about his unique and personal journey into this role – from foreign service to investment banking to this sector. “I had a family member who passed as a result of a rare disease – and that really activated my interest in what biotechnology could do,” Lewis explained, discussing his older brother. “His life was literally preserved for a much longer time than would have otherwise been the case. I always think about that. When you talk about the commitment to the patient and all that sort of stuff – and you’re running a business. And people say – how quickly does that get corrupted?
“It always brings it back to the personal for me – and I think for a lot of people,” Lewis continued. “If you are in health care, really checking yourself at the mirror and saying – what am I going to do today and why? And no matter how big or successful the company gets, you have to remember that if the medicine makes a difference in the patient’s lives – and the people around them who experience that, then you will generate the revenue. Then, the stock price will go up. It’s a derivative – it’s not the driver.
What’s next for Insmed?
Lewis was asked to describe some of the products and areas the company is focusing on.
“The trick, in my view, and I worked as a banker sort of supporting this industry as well as an operator within it,” said Lewis. “It comes from both sides of that experience. The most important thing you can do is prove that you can develop a drug and ultimately get it approved – and launch it. So, the first identification of Insmed is the creation, development, approval and launch of a drug called ARIKAYCE. It treats a respiratory condition. And with that success, we’ve been able to then layer in other development programs.
“The second development program has been astonishingly successful – and that is what has driven us on to the map of a lot of people, in the aftermath of what happened this year when the Phase III data, the last trial, showed positive results,” Lewis continued. “Think of us as taking one drug through that long journey and as we start to look like we are going to have success, we added some others. And those now start to look like they’re successful.”
Despite all of these positive developments and continued momentum – Lewis believes Insmed is still early in its journey.
“As much as we’ve changed and as much as we’ve grown, we literally are at the beginning right now of becoming the next great biotech company,” said Lewis. “And we have everything we need to do that, starting with people – coupled with those products. This is a really rare moment in biotech development where a company has really important, impactful products aligned with good people. And watch out, it just goes like an Elon Musk rocket into the air.”
New Jersey
NJ man finally faces quadruple murder trial, accused of killing brother’s family in Colts Neck fire horror
⚖️ Paul Caneiro is finally on trial, years after a brutal quadruple homicide and house fire stunned Monmouth County.
⚖️ Prosecutors say Caneiro murdered his brother, sister-in-law, and their two children in Colts Neck, then set multiple fires to cover it up.
⚖️ Years of delays: Attorney changes, legal motions, COVID disruptions, and appeals pushed one of NJ’s most notorious murder cases to this moment.
A New Jersey man accused of killing his brother and his family before setting their Monmouth County house on fire is finally facing trial.
Paul Caneiro was dealt a string of criminal charges, including four counts of first-degree murder, for the family massacre at a sprawling Colts Neck home more than seven years ago.
Keith Caneiro’s body was discovered on the front lawn by a landscaper two days before Thanksgiving in 2018. The bodies of Caneiro’s 45-year-old wife, Jennifer, and two children, 11-year-old Jesse and 8-year-old Sophia, were recovered from the wreckage.
Paul Caneiro was also accused of setting his own Ocean Township home on fire while his own family was inside.
The trial has been held up for years as Paul Caneiro’s rotating defense attorneys have filed repeated motions. He has maintained his innocence.
Here is a round-up of the harrowing deaths and what we know so far about the case.
Caneiro quadruple murder trial gets underway in 2026
Gruesome discovery of the Caneiro family, killed in Colts Neck
Keith Caneiro, 50, was shot four times in the head and once in the torso, before his lifeless body was recovered from his front lawn in Colts Neck.
His wife was shot in the head and stabbed in the torso, her body found near the stairs to their basement.
Their 11-year-old son was found in the kitchen, stabbed in the torso and arm, according to a 2019 lawsuit filed by Vlassis Karidis, Jennifer Caneiro’s father.
According to the lawsuit, based on a medical examiner’s findings, the youngest victim, Sophia, was the last to die and was still alive while the house was engulfed in flames, leading to lung damage and smoke inhalation that factored into her death.
She was found on the stairs leading to the second floor with stab wounds. The autopsy suggests that she suffered before she died based on an increase in white blood cells.
“Sophia survived her parents albeit with multiple stab wounds for an unimaginable period of time but demonstrably long enough to experience breathing difficulty and onset of high-degree stress,” the lawsuit says.
Karidis’ suit has been stayed for several years, pending the outcome of this criminal trial.
Read More: Lawsuit says girl, 8, suffered most in Colts Neck family homicide
Caneiro quadruple murder trial gets underway in 2026 – FILE photo of accused quadruple killer Paul Caneiro Monmouth County Prosecutors Office
Caneiro brothers as business partners, before being accused of fraud
Keith Caneiro started an IT consulting firm in 1989 and brought in his older brother with a 10% ownership interest, according to the 2019 lawsuit filed by Karidis, which also says the brothers took over a pest control company in 2011.
Attributing statements and messages shared with attorneys, the lawsuit said Keith and Jennifer Caneiro had accused Paul Caneiro of stealing tens of thousands of dollars from them and the businesses that the brothers held.
The night before he was killed, Keith Caneiro forwarded a company email stating that Paul Caneiro would no longer be paid his $225,000 salary, citing money missing from the business accounts, according to the lawsuit. The litigation is on hold pending this criminal trial.
In separate emails and messages cited by the lawsuit, Keith had said he was working to sell his companies and pursue a new position in order to be done dealing with his older brother.
About eight months before her brutal death, Jennifer Caneiro told her sister that her brother-in-law, that Caneiro had stolen thousands intended for her children’s trust and education funds, some of which he deposited into his own children’s education funds or used to pay down student loans.
The lawsuit also said that the Caneiros had voiced concerns to other family and friends about Paul Caneiro charging “excessive and improper personal expenses” to credit cards held by the businesses that he worked at with his brother.
Prosecutors say Paul Caneiro set two fires to cover up murders
The Colts Neck fire was reported around 1:30 p.m on Nov. 20, 2018, on Willow Brook Road. Investigators have said they believe Caneiro first killed his relatives and set the fire in Colts Neck before returning to his home about 5 a.m.
Prosecutors said the fire at Caneiro’s own house was both a “ruse” and an effort to destroy evidence that he had taken from the Colts Neck scene.
CBS New York shared helicopter footage of the Colts Neck fire as it was still being put out in 2018, as posted to YouTube.
The once-million-dollar property was cleared of the burned-out wreck by a demolition crew in 2020, Asbury Park Press reported.
Caneiro quadruple murder trial gets underway in 2026 – Paul Caneiro in court in 2018 CBS New York via Youtube
Why the Caneiro quadruple murder trial took more than seven years
Paul Caneiro started with a public defender before using several prominent defense attorneys in the following years. In February 2025, Monika Mastellone took over as defense attorney.
In December 2018, the Monmouth County Prosecutor’s Office had already said that a trial might not get underway until 2020. That was before the COVID-19 pandemic wreaked havoc on all court proceedings.
The state Supreme Court agreed in September to hear prosecutors’ appeal on one of Superior Court Judge Marc Lemieux’s rulings on evidence in the case, pushing jury selection to this month.
Last month, the state Supreme Court ruled that prosecutors can use a digital video recorder as evidence in Caneiro’s trial, despite it being taken without a warrant issued, NJ.com reported.
Seven years ago, CBS New York shared video of Caneiro’s first court appearance.
25 True Crime Locations: What Do They Look Like Today?
Below, find out where 25 of the most infamous crimes in history took place — and what the locations are used for today. (If they’ve been left standing.)
Report a correction 👈 | 👉 Contact our newsroom
All 31 convicted killers pardoned by Gov. Murphy
Since December 2024, Gov. Phil Murphy has granted clemency to 283 individuals convicted of various crimes. Of those, 31 have been pardoned and released early from state prison after they were convicted of murder and aggravated manslaughter. After their release, each killer is subject to five years of parole supervision.
Gallery Credit: Rick Rickman
New Jersey
Hischier | POST-RAW 1.4.26 | New Jersey Devils
NewJerseyDevils.com is the official web site of the New Jersey Devils, a member team of the National Hockey League (“NHL”). NHL, the NHL Shield, the word mark and image of the Stanley Cup and NHL Conference logos are registered trademarks of the National Hockey League. All NHL logos and marks and NHL team logos and marks as well as all other proprietary materials depicted herein are the property of the NHL and the respective NHL teams and may not be reproduced without the prior written consent of NHL Enterprises, L.P. Copyright © 1999-2025 New Jersey Devils and the National Hockey League. All Rights Reserved.
New Jersey
New Jersey didn’t wait for trends — this is what 2026 feels like here
Every year comes with its own personality, but New Jersey doesn’t wait around to see what the rest of the country decides is “in.” We move fast here. We adapt. We complain loudly — and then we make it part of our routine. Somewhere between a jughandle turn and a diner refill, 2026 developed a very Jersey personality. You may not have noticed it happening, but you’re already living it.
Here are 10 things that feel unmistakably so 2026, Garden State edition.
The way New Jersey talks now (and what it really means)
Calling every inconvenience “a situation.”
Traffic? Situation. School drop-off? Situation. The coffee machine acting up? Full-blown situation.
Quietly flexing about not pumping gas.
We don’t brag. We just casually mention it… often.
Errands, routines and the New Jersey sense of time
Planning an entire weekend around one errand.
Costco, Home Depot, or MVC — choose wisely and clear your schedule.
Checking Dan Zarrow’s forecast on the NJ101.5 app religiously.
Because if you’re going to trust the weather, it might as well be someone who knows New Jersey.
Having a “favorite small town” you don’t live in.
You’ve “been a few times.” You “get the vibe.”
ASSOCIATED PRESS
Roads, tolls and the daily traffic psychology of NJ
Treating tolls like a personal betrayal.
Every increase feels targeted, and we all do the same mental math at the booth anyway.
Explaining traffic circles and roundabouts like a survival skill.
Somehow we all know exactly what to do — except when we don’t.
Money stress, comfort food and Garden State coping mechanisms
Treating diners as emotional support buildings.
Coffee refills fix things. It’s science.
Complaining about taxes while never actually leaving.
Because deep down, we know better.
Comparing energy bills like it’s a competitive sport.
Nobody likes the numbers, but everyone wants to know if theirs is worse.
The truth is, 2026 in New Jersey isn’t about trends you see online. It’s about habits, shortcuts, shared frustrations, and small victories we all pretend are normal. And if you read this nodding along, congratulations — you’re not behind the times. You’re just right on schedule… in New Jersey.
Best New Jersey Diners For Breakfast and Lunch
Thank you to our New Jersey listeners for these recommendations.
Gallery Credit: Bill Spadea
-
World1 week agoHamas builds new terror regime in Gaza, recruiting teens amid problematic election
-
Business1 week agoGoogle is at last letting users swap out embarrassing Gmail addresses without losing their data
-
Indianapolis, IN1 week agoIndianapolis Colts playoffs: Updated elimination scenario, AFC standings, playoff picture for Week 17
-
Southeast1 week agoTwo attorneys vanish during Florida fishing trip as ‘heartbroken’ wife pleads for help finding them
-
News1 week agoRoads could remain slick, icy Saturday morning in Philadelphia area, tracking another storm on the way
-
Politics1 week agoMost shocking examples of Chinese espionage uncovered by the US this year: ‘Just the tip of the iceberg’
-
News1 week agoMarijuana rescheduling would bring some immediate changes, but others will take time
-
World1 week agoPodcast: The 2025 EU-US relationship explained simply

